Rangsubbs Pharmaceuticals (India) Private Limited, a active private limited company, was established on 24 August 2017 in Shaikpet, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24302TG2017PTC119103. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.39 Cr.
It upholds a compliant status. Employing 1 professional, Its leadership includes Srinivas Rao Naga Boyalapalli (Managing Director), Devarakonda Ravi Sankar (Director). Past directors included Srinivas Rao Naga Boyalapalli, Gangarapu Reddeppa Naidu, Lakshmanbabu Cheemaladinne. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at Aparna Aura Apartments, Flat No 906, Road No 79, Jubilee Hills, Shaikpet, Telangana, 500096.
U24302TG2017PTC119103
119103
24 August 2017
₹1.50 Cr
₹1.39 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Rangsubbs Pharmaceuticals (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srinivas Rao Naga Boyalapalli | Managing Director | 24 Aug 2017 | Current |
| Devarakonda Ravi Sankar | Director | 16 Aug 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 26 Aug 2021 | Past |
| Pramod Abcsdd | Managing Director | 21 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 May 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rangsubbs Pharmaceuticals (India) Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2018, Rangsubbs Pharmaceuticals (India) had a promoter holding of 55.10% and a public holding of 44.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Rangsubbs Pharmaceuticals (India) has a workforce of 1 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rangsubbs Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rangsubbs Pharmaceuticals (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Devarakonda Ravi Sankar was appointed as a Director was appointed as a Director on 16 Aug 2021 & has been associated with this company since 4 years 4 months . was documented.
The activity Rangsubbs Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was completed.
Progress on Rangsubbs Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Hyderabad. was documented.
Progress on Srinivas Rao Naga Boyalapalli was appointed as a Managing Director was appointed as a Managing Director on 24 Aug 2017 & has been associated with this company since 8 years 4 months . was documented.
The activity Rangsubbs Pharmaceuticals (India) Private Limited was registered on 24 Aug 2017 with Roc Hyderabad & aged 8 years 4 months as per MCA records. was completed.
The CIN of Rangsubbs Pharmaceuticals (India) Private Limited is U24302TG2017PTC119103.
Rangsubbs Pharmaceuticals (India) Private Limited is headquartered at Aparna Aura Apartments, Flat No 906, Road No 79, Jubilee Hills, Shaikpet, Telangana, 500096.
Rangsubbs Pharmaceuticals (India) Private Limited was incorporated on 24 August 2017.
The current directors of Rangsubbs Pharmaceuticals (India) Private Limited are
The primary industry of Rangsubbs Pharmaceuticals (India) Private Limited is Pharma.
Rangsubbs Pharmaceuticals (India) Private Limited is unlisted.
The authorized capital of Rangsubbs Pharmaceuticals (India) Private Limited is ₹1.50 Cr, and the paid-up capital is ₹1.39 Cr.
The compliance status of Rangsubbs Pharmaceuticals (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX